News and Community

Chief Medical Officer, Drug Administration, Genentech, Healthcare Technology, Kras G12c, Oncology

July 2, 2026

Genentech’s Divarasib Proves Superiority in Head-to-Head Phase III Trial Against Approved KRAS G12C Inhibitors in Non-Small Cell Lung Cancer

Autoimmune Symptoms, Chief Medical Officer, Enspryng, Genentech, Healthcare Technology, Thyroid Eye Disease

June 30, 2026

FDA Accelerates Genentech’s Application for Enspryng, the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease

Caresource Georgia, Chief Medical Officer, Clinical Strategy, Healthcare Leadership, Managed Care Organization, Population Health

June 18, 2026

CareSource Georgia Names Dr. Tamika Lasege as Chief Medical Officer

Chief Medical Officer, Chronic Disease, Clinical Strategy, Mdvip, Physician Experience, Preventive Care

April 23, 2026

MDVIP Names Dr. Jeffrey Lin as Chief Medical Officer to Strengthen Preventive Care

Chief Medical Officer, Clinical Excellence, Healthcare Leadership, Memorial Healthcare System, Patient Safety, Physician Executive

March 10, 2026

Memorial Hospitals Miramar and Pembroke Announce Dr. LaKeeya Tucker as New Chief Medical Officer